The global medical marijuana market is experiencing robust growth, with worldwide revenue reaching US$ 34 billion in 2024. Market analysts anticipate an impressive CAGR of 16%, propelling the market to a valuation of US$ 95 billion by the end of 2031, according to a comprehensive market analysis report.
This product will be delivered within 1-3 business days.
Factors Driving the Growth of the Medical Marijuana Market
The medical marijuana market is set to flourish, driven by several key factors:
- Rise in the Number of Social Clubs Promoting Medical Marijuana: Social groups, commonly known as marijuana clubs, are playing a pivotal role in changing the perception of medical marijuana. These clubs aim to diminish negative stereotypes associated with medical marijuana, emphasizing its therapeutic benefits. The establishment of such clubs has led to increased acceptance and demand for medical marijuana, especially in countries where legalization is evolving.
- Expanding Use of Marijuana in the Healthcare Industry: Growing legalization for medicinal and recreational use, coupled with increasing research and development activities, is driving the use of medical marijuana in the healthcare industry. Marijuana's potential in treating chronic diseases, which constitute a significant health burden, is contributing to rapid market growth.
- Increasing FDA Approvals: Key players in the market are focusing on gaining FDA approval for their cannabis-derived products, enhancing their efficacy and acceptance in the medical field. The FDA's approval of medications containing cannabis-derived active components for treating rare genetic diseases has opened new avenues for growth.
Challenges Impacting Market Growth
Despite the promising growth prospects, the medical marijuana market faces certain challenges:
- Societal Stigma Related to Marijuana: Negative societal perceptions and stigma surrounding medical marijuana can hinder its acceptance and growth. Public perception plays a crucial role in the success of the medical marijuana industry, and regulatory investigations and scientific studies are needed to change these perceptions.
- Black Market Competition: The persistent presence of a black market for marijuana, offering unregulated products at lower prices, remains a challenge. The ease of access and affordability of black market marijuana products pose competition to the legal medical marijuana market and hinder its growth.
Country-wise Insights
- U.S. Market: The United States is witnessing a surge in demand for medical marijuana, largely due to FDA approval for its use in treating epilepsy. The number of U.S. citizens participating in medical marijuana programs has quadrupled since 2016, exceeding 2.97 million in 2020.
- German Market: Germany has embraced medical marijuana for treating various health issues. Specific laws and initiatives allow patients to use marijuana-based medications, making it a lucrative market for medical marijuana manufacturers.
- Mexican Market: Mexico has recently regulated the use of medical cannabis, enabling research and pharmaceutical product production. This move is expected to boost the adoption of medical marijuana in the healthcare industry, driving market expansion.
Competitive Landscape
As the medical marijuana market gains traction globally, early adopters are expected to solidify their market dominance. Manufacturers are strategically positioning themselves through partnerships, acquisitions, and agreements to expand product lines and navigate regulatory complexities.Key Companies’ Profiled
- Tilray
- Aurora Cannabis
- Canopy Growth Corporation
- Aphria, Inc.
- Maricann Group, Inc.
- Tikun Olam, Ltd.
- MedReleaf. Corp.
- GW Pharmaceuticals plc.
- Cannabis Sativa, Inc.
- Medical Marijuana, Inc.
Key Segments Covered in Medical Marijuana Industry Research
Product:
- Dried flower
- Extract Form
Indication:
- Pain Management
- Seizure
- Others
Distribution Channel:
- Retail pharmacies
- E-commerce
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Medical Marijuana Market Outlook, 2018 - 2031
4. North America Medical Marijuana Market Outlook, 2018 - 2031
5. Europe Medical Marijuana Market Outlook, 2018 - 2031
6. Asia Pacific Medical Marijuana Market Outlook, 2018 - 2031
7. Latin America Medical Marijuana Market Outlook, 2018 - 2031
8. Middle East & Africa Medical Marijuana Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned
- Tilray
- Aurora Cannabis
- Canopy Growth Corporation
- Aphria, Inc.
- Maricann Group, Inc.
- Tikun Olam, Ltd.
- MedReleaf. Corp.
- GW Pharmaceuticals plc.
- Cannabis Sativa, Inc.
- Medical Marijuana, Inc.
Methodology
LOADING...